Literature DB >> 31146008

Insulin Modulates Excitatory Synaptic Transmission and Synaptic Plasticity in the Mouse Hippocampus.

Fangli Zhao1, Jason J Siu1, Wei Huang1, Candice Askwith1, Lei Cao2.   

Abstract

The administration of exogenous insulin into the hippocampus has the potential to enhance cognitive function and exert other beneficial effects. Elucidating the neurobiological substrates of insulin action and its underlying physiological mechanisms may further improve treatment efficacy. Previous work has shown that insulin affects synaptic plasticity, however there are discrepancies and contradictory conclusions between studies. Here, we used extracellular field recordings in mouse hippocampal slices to investigate how insulin acutely modulates synaptic transmission and synaptic plasticity, both of which are correlated with learning and memory processes. Our data demonstrate that insulin application inhibited basal excitatory synaptic transmission and promoted long-term potentiation (LTP) induction at hippocampal Schaffer collateral-CA1 synapses. Under similar conditions, insulin strongly activated the PI3K/AKT pathway, but had only a weak effect on the MAPK/ERK pathway. Although insulin-induced inhibition of field excitatory post-synaptic potentials (fEPSPs) was previously termed insulin-long-term depression (insulin-LTD), insulin application potentiated recovery from classically induced LTD. Further analysis suggests suppression of presynaptic neurotransmitter release contributed to the insulin-LTD. At low concentrations, insulin primarily inhibited fEPSPs; however, at high concentration, its effects were of mixed inhibition and enhancement in different recordings. Moreover, a broad spectrum protein kinase C blocker, cannabinoid receptor type 1 activator, or a high glucose concentration inhibited fEPSPs per se, and disturbed insulin's effect on fEPSP. Insulin also caused depotentiation during LTP expression and triggered depression during LTD recovery. Given the essential roles of dynamic synaptic transmission and plasticity in learning and memory, our data provide more evidence that insulin application may actively modulate hippocampal-dependent cognitive events.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  LTD; LTP; hippocampus; insulin

Mesh:

Substances:

Year:  2019        PMID: 31146008      PMCID: PMC6612444          DOI: 10.1016/j.neuroscience.2019.05.033

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  100 in total

1.  Hippocampal long-term depression and long-term potentiation encode different aspects of novelty acquisition.

Authors:  Anne Kemp; Denise Manahan-Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

Review 2.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

3.  Modulation of AMPA excitatory postsynaptic currents in the spinal cord dorsal horn neurons by insulin.

Authors:  D Spicarova; J Palecek
Journal:  Neuroscience       Date:  2009-12-23       Impact factor: 3.590

Review 4.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

Review 5.  Insulin receptor signaling in normal and insulin-resistant states.

Authors:  Jérémie Boucher; André Kleinridders; C Ronald Kahn
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

6.  Spatial exploration induces a persistent reversal of long-term potentiation in rat hippocampus.

Authors:  L Xu; R Anwyl; M J Rowan
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

Review 7.  Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse.

Authors:  J F Oliveira da Cruz; L M Robin; F Drago; G Marsicano; M Metna-Laurent
Journal:  Neuroscience       Date:  2015-05-09       Impact factor: 3.590

8.  A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity.

Authors:  H Kang; E M Schuman
Journal:  Science       Date:  1996-09-06       Impact factor: 47.728

9.  Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents.

Authors:  Lin Xu; Nicholas Rensing; Xiao-Feng Yang; Hai Xia Zhang; Liu Lin Thio; Steven M Rothman; Aryan E Weisenfeld; Michael Wong; Kelvin A Yamada
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 10.  The rise and fall of insulin signaling in Alzheimer's disease.

Authors:  B Chami; A J Steel; S M De La Monte; Greg T Sutherland
Journal:  Metab Brain Dis       Date:  2016-02-16       Impact factor: 3.584

View more
  9 in total

1.  Metforminium Decavanadate (MetfDeca) Treatment Ameliorates Hippocampal Neurodegeneration and Recognition Memory in a Metabolic Syndrome Model.

Authors:  Alfonso Diaz; Guadalupe Muñoz-Arenas; Berenice Venegas; Rubén Vázquez-Roque; Gonzalo Flores; Jorge Guevara; Enrique Gonzalez-Vergara; Samuel Treviño
Journal:  Neurochem Res       Date:  2021-02-09       Impact factor: 3.996

Review 2.  Impaired insulin signalling and allostatic load in Alzheimer disease.

Authors:  Fernanda G De Felice; Rafaella A Gonçalves; Sergio T Ferreira
Journal:  Nat Rev Neurosci       Date:  2022-02-28       Impact factor: 34.870

3.  Sleep fragmentation engages stress-responsive circuitry, enhances inflammation and compromises hippocampal function following traumatic brain injury.

Authors:  Zoe M Tapp; Sydney Cornelius; Alexa Oberster; Julia E Kumar; Ravitej Atluri; Kristina G Witcher; Braedan Oliver; Chelsea Bray; John Velasquez; Fangli Zhao; Juan Peng; John Sheridan; Candice Askwith; Jonathan P Godbout; Olga N Kokiko-Cochran
Journal:  Exp Neurol       Date:  2022-03-28       Impact factor: 5.620

4.  Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease.

Authors:  Jeffrey Cummings; Andrew Ortiz; Janelle Castellino; Jefferson Kinney
Journal:  Eur J Neurosci       Date:  2022-02-06       Impact factor: 3.698

5.  Translational regulation in the brain by TDP-43 phase separation.

Authors:  Ju Gao; Luwen Wang; Xiaojia Ren; Justin R Dunn; Ariele Peters; Masaru Miyagi; Hisashi Fujioka; Fangli Zhao; Candice Askwith; Jingjing Liang; Xinglong Wang
Journal:  J Cell Biol       Date:  2021-08-24       Impact factor: 8.077

Review 6.  Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.

Authors:  Sara Al Hussein Al Awamlh; Lauren K Wareham; Michael L Risner; David J Calkins
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

7.  Aconiti lateralis Radix Praeparata inhibits Alzheimer's disease by regulating the complex regulation network with the core of GRIN1 and MAPK1.

Authors:  Yutao Wang; Huixiang Zhang; Jing Wang; Ming Yu; Qianqian Zhang; Shan Yan; Dingyun You; Lanlan Shi; Lihuan Zhang; Limei Wang; Hongxiang Wu; Xue Cao
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

8.  Cognitive impairment in obese rat model: role of glial cells.

Authors:  Reham M Wahid; Walaa Samy; Sherein F El-Sayed
Journal:  Int J Obes (Lond)       Date:  2021-06-17       Impact factor: 5.095

9.  Activation of Hippocampal IR/IRS-1 Signaling Contributes to the Treatment with Zuogui Jiangtang Jieyu Decoction on the Diabetes-Related Depression.

Authors:  Hui Yang; Jia Ling; Pan Meng; Jian Liu; Xiaoyuan Lin; Wei Li; Yuhong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-03       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.